Akero Therapeutics Inc. (AKRO)
undefined
undefined%
At close: undefined
27.11
-1.92%
Pre-market Jan 07, 2025, 06:44 AM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -151.76M -112.03M -100.78M -79.21M -43.76M -81.71M -4.56M
Depreciation & Amortization 29.00K 43.00K 41.00K 17.00K -104.00K n/a n/a
Stock-Based Compensation 21.50M 23.24M 10.05M 6.02M 1.77M 121.00K n/a
Other Working Capital -6.03M -5.43M 6.45M -396.00K 6.89M -252.00K 122.00K
Other Non-Cash Items -8.46M 689.00K 203.00K 196.00K -104.00K 75.91M -60.00K
Deferred Income Tax n/a n/a 1.07M 83.00K 104.00K n/a n/a
Change in Working Capital -6.67M -4.46M 9.73M 2.08M 6.46M 1.06M 182.00K
Operating Cash Flow -145.37M -92.52M -79.68M -70.80M -35.63M -4.63M -4.38M
Capital Expenditures n/a n/a n/a -148.00K n/a -5.00M n/a
Acquisitions n/a n/a n/a 9.61K n/a n/a n/a
Purchase of Investments -433.12M -101.45M -43.56M -115.04M -71.51M n/a n/a
Sales Maturities Of Investments 209.50M 37.62M 85.84M 105.42M n/a n/a n/a
Other Investing Acitivies n/a -63.83K 42.28K -9.61K -71.51K -5.00K n/a
Investing Cash Flow -223.62M -63.83M 42.28M -9.76M -71.51M -5.00M n/a
Debt Repayment 15.00M 10.00M n/a n/a n/a n/a n/a
Common Stock Repurchased n/a n/a 373.00K n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 2.89M 4.43M 602.00K 553.00K 536.00K 85.01M 5.00M
Financial Cash Flow 353.32M 255.63M 602.00K 203.11M 95.99M 85.01M 5.00M
Net Cash Flow -15.67M 99.29M -36.80M 122.54M -11.15M 75.38M 618.00K
Free Cash Flow -145.37M -92.52M -79.68M -70.95M -35.63M -9.63M -4.38M